This event is part of our monthly Lung Webinar Series - 60-minute, educational webinars on updates in clinical practice, research & development, technology & drug advancements in the treatment of Lung Cancer. This will be a great opportunity to learn from key opinion leaders along with engaging in professional exchange of ideas.

Moderated by Hatim Husain, MD, UC San Diego and discussants: Dr. Goldman, UCLA, and Dr. Riess, UC Davis on the Treatment of EGFR NSCLC (Classical Mutations). Sponsored in part by Janssen Oncology.

**This webinar is open to medical oncologists/hematologists, nurses, nurse practitioners, physician assistants, and other clinical personnel.

(Pharma participation is by invitation only.)